Book an Appointment
Emergency: 022-61305005
I want to find
My Health Records
Management Team

Nonalcoholic Fatty Liver Disease (NAFLD)

Overview

Nonalcoholic Fatty Liver Disease (NAFLD) refers to the accumulation of excess fat in the liver in people who consume little or no alcohol. It is a spectrum of liver conditions, which can progress from simple fatty liver (steatosis) to more severe forms like nonalcoholic steatohepatitis (NASH), cirrhosis, and even liver cancer.

The exact cause of NAFLD is not fully understood, but several factors contribute to its development:

  • Insulin resistance: The liver becomes more likely to store fat when the body becomes resistant to insulin. This is often associated with obesity, type 2 diabetes, and metabolic syndrome.
  • Obesity: Excess body fat, especially abdominal fat, significantly increases the risk of NAFLD.
  • Poor diet: Diets high in sugars, refined carbohydrates, and unhealthy fats can contribute to fat buildup in the liver.
  • Genetics: Genetic factors can predispose individuals to develop NAFLD, though the exact genes involved are still being studied.
  • Metabolic syndrome: Conditions like high blood pressure, high cholesterol, and high triglycerides can increase the likelihood of developing NAFLD.
  • Medications: Certain medications, such as corticosteroids, some cancer drugs, and anti-retroviral drugs, can contribute to the development of fatty liver.

Several factors increase the likelihood of developing NAFLD:

  • Obesity: Overweight individuals are at higher risk, especially those with a higher amount of abdominal fat.
  • Type 2 diabetes: Insulin resistance associated with diabetes often contributes to the development of fatty liver disease.
  • High cholesterol or triglycerides: People with dyslipidaemia (abnormal levels of fats in the blood) have an increased risk.
  • Sedentary lifestyle: Lack of physical activity can contribute to obesity and insulin resistance, both of which are risk factors for NAFLD.
  • Age: The risk increases with age, especially in individuals over 40.
  • Gender: Men are more likely to develop NAFLD, but postmenopausal women also have an elevated risk.
  • Genetics: Family history of NAFLD or other liver diseases increases the risk.
  • Other medical conditions: Conditions such as polycystic ovary syndrome (PCOS), hypothyroidism, and sleep apnea can increase the risk.

In the early stages, NAFLD often does not cause noticeable symptoms. However, as the condition progresses, some individuals may experience:

  • Fatigue
  • Abdominal discomfort or pain (especially in the upper right side of the abdomen)
  • Weight loss (in advanced stages)
  • Enlarged liver (hepatomegaly), which can be detected during a physical examination.
  • Jaundice in advanced cases with cirrhosis.
  • However, many individuals with NAFLD may remain asymptomatic until the disease reaches more severe stages, such as cirrhosis.

  • Blood tests: These can check for liver enzyme levels (ALT, AST) and other markers of liver function. While abnormal results may indicate liver damage, they are not conclusive for diagnosing NAFLD.
  • Imaging tests:
    • Ultrasound: The most common method for detecting fat in the liver. It’s non-invasive and can show liver enlargement or fatty changes.
    • CT Scan or MRI: These can also detect fat accumulation and assess liver structure.
  • Liver biopsy: If NASH or cirrhosis is suspected, a liver biopsy may be performed to assess the extent of liver damage. A biopsy is the gold standard for diagnosing NASH and determining the severity of liver damage.
  • FibroScan (Transient Elastography): This test measures liver stiffness, which is an indicator of fibrosis (scarring of the liver). It can help assess the extent of liver damage.

There is no FDA-approved medication specifically for treating NAFLD, but management focuses on lifestyle changes, monitoring, and treating related conditions.

  • Weight loss:
    • Diet: A balanced, healthy diet is essential. Low-calorie, low-fat diets, and diets high in fruits, vegetables, and whole grains are recommended. Reducing sugar intake, especially refined carbs, is important.
    • Exercise: Regular physical activity can help reduce liver fat, improve insulin sensitivity, and reduce obesity.
  • Control of risk factors:
    • Diabetes management: Keeping blood sugar levels under control is crucial.
    • Lowering cholesterol/triglycerides: Statins or other lipid-lowering medications may be prescribed if high cholesterol or triglycerides are present.
    • Blood pressure control: Managing hypertension can reduce the risk of complications.
  • Medications:
    • While no specific drugs for NAFLD exist, certain treatments may be used to manage related conditions:
    • Vitamin E may be prescribed for individuals with NASH (though it’s not suitable for everyone).
    • Pioglitazone (a diabetes medication) can sometimes be used in NASH with insulin resistance.
    • Avoiding alcohol and hepatotoxic drugs: People with NAFLD should avoid alcohol, which can worsen liver damage. Additionally, certain drugs that can stress the liver should be avoided.
  • Liver transplant: In cases of cirrhosis or end-stage liver failure, a liver transplant may be necessary.

Healthy lifestyle choices are the most effective way to prevent NAFLD. This includes maintaining a healthy weight, eating a balanced diet, exercising regularly, and managing underlying conditions such as diabetes and high blood pressure.

Bottom to top